Effects of valsartan on fibrinolysis in hypertensive patients with metabolic syndrome.
Miyata M, Ikeda Y, Nakamura S, Sasaki T, Abe S, Minagoe S, Torii H, Lee S, Tateishi S, Kihara K, Ohba I, Kajiya S, Furusho Y, Hamasaki S, Tei C; Kagoshima Collaborate Trial in Metabolic Syndrome (KACT-MetS) Investigators.
Miyata M, et al.
Circ J. 2012;76(4):843-51. doi: 10.1253/circj.cj-12-0153.
Circ J. 2012.
PMID: 22451451
Free article.
Clinical Trial.